Search Results
Results found for "David M. Thal"
- How GPCR Collaboration Built an Innovation Engine
Rather than carving out turf, they grew by designing around collective capacity . environment lowers friction between these specialties, making innovation structurally inevitable rather than The structure you train in often matters more than the experiment you start with. Weekly seminars were mandatory but lightweight, designed to connect Ā rather than perform.
- From Student to Mentor: What Alessandro Nicoli Learned About Leading in Science
Watch Episode 171 Mentoring in science is more than supervisingāitās about shaping the next generation Mistakes are part of learningāand guiding students through them is more valuable than doing everything
- Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial ...
Methods: Rats were divided into sham, sham + Exendin-4 (10 μg/day, i.p), MI, and MI + Exendin-4.
- Building Backwards: Why Top-Down Models Could Revolutionize Pain Research
development... seeing if we can bring preclinical models much closer to the actual human experience than Rather than starting with a molecular hypothesis, Serafiniās team noticed that hamsters infected with
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Earlier than many teams do. Modern real-time assays can deliver these insights earlier, faster, and cheaper than most teams assume Itās less bureaucratic than most outsiders think. Why kinetic profiling matters more than most teams realize.
- Understanding Biased Signaling in GPCRs
illustrates how arrestin signaling can be stabilized through direct receptorāGαo interface engagement rather than implications: Binding and function probe different receptor populations, so discrepancies are expected rather than Read article ⤠Biased signaling can also be framed as circuit-level organization rather than binary switching
- Unlock the Hidden Lives of Receptors ā Are You Ready?
With the right lens, youāll see why efficacy is more than signal strength: it's a fingerprint of conformational
- The Hidden Cost of Unclear Biotech Positioning
š Most biotech founders experience that external conversations consume more energy than they should Each external interaction becomes reactive, shaped more by incoming questions than by strategic intent It becomes an asset that reinforces clarity rather than competing with it. established early Questions move from explanation to evaluation , signaling real engagement rather than Even rejection becomes useful, because it is based on clear criteria rather than confusion. ā A biotech
- Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines
agonist responses to a common reference window Accepting that maximal response may be estimated rather than exact In practice, the precise maximal signal matters less than many assume. ECā ā Misconceptions Persist Few misunderstandings derail discovery programs faster than misinterpreting Time Matters More Than Potency For decades, discovery teams prioritized potency above all else.
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Less than ~15% of higher plant species, <5% of bacterial and fungal species, and only a fraction of marine This was more than trial-and-error. It was early structure-based pharmacology. Dr. expands drug matter beyond the familiar and encourages deliberate exploration of chemical novelty, rather than
- Ever Wondered How Drugs Are Discovered?
unique ability to combine storytelling, real-world experience, and scientific clarity makes this more than
- Dr. GPCR Updates
article GPCR Publication Highlights βCGRP breaks the mold: Distinct signaling patterns reveal itās more than
- GPCR Happy Hour Boston 2026 ā April 29 | Dr. GPCR Community Event
EuroscreenFast EuroscreenFast has been a pioneer in GPCR science for more than 30 years,. Today, their catalogue includes over 1,000 functional assays representing more than 550 GPCR and other
- How to Avoid the Most Common Gaps in Your Biotech Pitch
For biotech founders, this is more than a presentation problem. Itās a strategic vulnerability. academic interest to practical significance. 3ļøā£ Why itās different ā Differentiation must be more than who youāre building for, why now is the right time, and how your solution fits into something bigger than
- Antibodies That Donāt Block, They Activate: A New Angle on Autoimmunity and GPCRs
.ā ā Tom Sakmar This makes them more than biomarkers ā theyāre potential drivers of disease .
- The Hidden Cost of Ambition in Biotech Leadership
. š The problem begins when ambition grows faster than structure. This is where the structural tension begins. š Scientific optionality grows faster than strategic capacity And this is where biotech fundraising begins to feel harder than it should.
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
DiscoverX Partnership ā Tools and Insight for GPCR Drug Discovery Modern GPCR discovery depends on more than DiscoverX , a global provider of GPCR assay platforms and translational biology services covering more than
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
science well, but not the value capture From an investor's perspective, this creates confusion rather than š IP discussions happen earlier in fundraising conversations š Investors look for alignment rather than Biotech fundraising will favor teams that use intellectual property as a tool for clarity rather than
- The Real Cost of Strategic Overload in Biotech
becomes unclear š Capital allocation appears fragmented š The development timeline looks crowded rather than And uncertainty, even when the science is strong, slows biotech fundraising more than most founders expect Saying yes often feels safer than saying no.
- The Hidden Operating Cadence Thatās Actually Driving Your Biotech
Timeline slips are absorbed as āpart of biologyā rather than examined as managerial signals. start planning around delays BD and investor messaging drifts Timelines become aspirational rather than
- The Moment Biotech Founders Realize the Money Is Gone
. š How long can we operate if fundraising takes longer than expected? visibility fades while the company keeps moving forward , until choices are driven by urgency rather than That shift creates space to act deliberately again, rather than being pushed forward by circumstances
- How System-Level GPCR Thinking Prevents Discovery Failures
Most GPCR programs donāt fail because of weak moleculesāthey fail because biology behaves differently than Translate potency and efficacy realistically Ā ā Recognize when deviations reflect biology rather than
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
By visualizing enzymes as dynamic molecular partners rather than static filters, drug discovery scientists Cytochrome P450: Friend, Foe, and FDA Focus No enzyme class is more importantāor more unpredictableāthan Yet many discovery teams still relegate them to the āADMEā checklist, rather than the strategic design
- GPCR Internalization: When the Signal Moves Inside the Cell
The analog AOP-RANTES also internalizes CCR5, but drives the receptor toward degradation rather than And judicious tag placement on endosomal markers, rather than the receptor itself, allows detection of
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
obvious mistakes , and why preventing that drift requires a different kind of leadership awareness than Founders often sense this as friction rather than failure. Meetings feel heavier. organizationally. š By the time leadership recognizes the gap, correcting course requires far more effort than
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
Recent studies showed that some AVPR2 mutations could cause biased Gαq/11 protein coupling rather than R68W showed bias to coupling with Gαq/11 protein rather than V162A and wild-type receptor.
- Early Stage Biotech Hiring: What Really Holds a Team Together When the Science Starts to Drift
The science evolves, assumptions break, and timelines shift quietly rather than dramatically. The discovery phase stretches longer than planned. The right ones also know when progress matters more than perfection. š These signals are subtle, but
- Learn about Dr. GPCR Ecosystem!
GPCR is much more than a podcast? Come check out the brand new Dr.
- Roles of Focal Adhesion Kinase PTK2 and Integrin αIIbβ3 Signaling in Collagen- and GPVI-Dependent...
The suppressive rather than activating effects of pGRP were confined to blood flow at a high shear rate Blockage of PTK2 or interference of CIB1 no more than slightly affected thrombus formation at a low shear
- When January Looks Different by March: Orthosteric vs. Allosteric Insights from Our Latest AMA
designed as a continuous learning environment ā supporting scientific reasoning as programs mature, rather than Misinterpretation does more than delay progress.



























